S. Sivgin Et Al. , "Efficacy and safety of oral deferasirox treatment in the posttransplant period for patients who have undergone allogeneic hematopoietic stem cell transplantation (alloHSCT)," ANNALS OF HEMATOLOGY , vol.91, no.5, pp.743-749, 2012
Sivgin, S. Et Al. 2012. Efficacy and safety of oral deferasirox treatment in the posttransplant period for patients who have undergone allogeneic hematopoietic stem cell transplantation (alloHSCT). ANNALS OF HEMATOLOGY , vol.91, no.5 , 743-749.
Sivgin, S., ESER, B., Bahçebaşı, S., KAYNAR, L., kurnaz, F., Uzer, E., ... Pala, C.(2012). Efficacy and safety of oral deferasirox treatment in the posttransplant period for patients who have undergone allogeneic hematopoietic stem cell transplantation (alloHSCT). ANNALS OF HEMATOLOGY , vol.91, no.5, 743-749.
Sivgin, Serdar Et Al. "Efficacy and safety of oral deferasirox treatment in the posttransplant period for patients who have undergone allogeneic hematopoietic stem cell transplantation (alloHSCT)," ANNALS OF HEMATOLOGY , vol.91, no.5, 743-749, 2012
Sivgin, Serdar Et Al. "Efficacy and safety of oral deferasirox treatment in the posttransplant period for patients who have undergone allogeneic hematopoietic stem cell transplantation (alloHSCT)." ANNALS OF HEMATOLOGY , vol.91, no.5, pp.743-749, 2012
Sivgin, S. Et Al. (2012) . "Efficacy and safety of oral deferasirox treatment in the posttransplant period for patients who have undergone allogeneic hematopoietic stem cell transplantation (alloHSCT)." ANNALS OF HEMATOLOGY , vol.91, no.5, pp.743-749.
@article{article, author={Serdar ŞIVGIN Et Al. }, title={Efficacy and safety of oral deferasirox treatment in the posttransplant period for patients who have undergone allogeneic hematopoietic stem cell transplantation (alloHSCT)}, journal={ANNALS OF HEMATOLOGY}, year=2012, pages={743-749} }